Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.88−0.09 (-1.81%)
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Clover Health Investments ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Clover Health Investments's ebitda for the twelve months ending Sep 30, 2026 was $12.68M. For fiscal 2025 it was -$87.37M. The highest annual figure on record is -$48.27M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$87.37M | – |
| FY2024 | Dec 31, 2024 | -$48.27M | – |
| FY2023 | Dec 31, 2023 | -$209.34M | – |
| FY2022 | Dec 31, 2022 | -$288.17M | – |
| FY2021 | Dec 31, 2021 | -$636.79M | – |
| FY2020 | Dec 31, 2020 | -$92.90M | – |
| FY2019 | Dec 31, 2019 | -$186.06M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.05M | – |
| Q2 FY2026 | Jun 30, 2026 | $28.57M | – |
| Q1 FY2026 | Mar 31, 2026 | $26.89M | – |
| Q4 FY2025 | Dec 31, 2025 | -$49.82M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.97M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.17M | -235.2% |
| Q1 FY2025 | Mar 31, 2025 | -$1.71M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.83M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.45M | – |
| Q2 FY2024 | Jun 30, 2024 | $7.52M | – |
| Q1 FY2024 | Mar 31, 2024 | -$23.37M | – |
| Q4 FY2023 | Dec 31, 2023 | -$64.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$33.06M | – |
| Q2 FY2023 | Jun 30, 2023 | -$27.88M | – |
| Q1 FY2023 | Mar 31, 2023 | -$82.95M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.13M | – |
| Q3 FY2022 | Sep 30, 2022 | -$73.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$102.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$87.50M | – |
| Q4 FY2021 | Dec 31, 2021 | -$186.73M | – |
| Q3 FY2021 | Sep 30, 2021 | -$149.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$181.74M | -879.2% |
| Q1 FY2021 | Mar 31, 2021 | -$119.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$67.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$21.48M | – |
| Q2 FY2020 | Jun 30, 2020 | $23.32M | – |
| Q1 FY2020 | Mar 31, 2020 | -$27.00M | – |
See a number that looks wrong?